Results: Overall, 190 procedures were performed by 7 vascular surgeons at 3 institutions between 2013 and 2017. The mean procedural time for all cases was 68.9 6 9.5 minutes (Fig) . When the procedural time of cases 1 to 10 (mean, 74.8 6 9.6 minutes) was compared with that of cases 11 to 50 (mean, 67.5 6 9.0 minutes), a significant difference was noted (P ¼ .014). ANOVA results between all bins of procedural times showed that the first 5 cases were statistically longer than cases 31 to 50. Mean flow reversal time was 9.7 6 3.5 minutes. When flow reversal times were compared using ANOVA testing, cases 1 to 10 were statistically similar and all cases within 11 to 50 were also similar, but the two groups differed from each other (P < .001). For flow reversal time, the first 10 cases had mean reversal times of 14.5 6 3.7 minutes compared with 8.6 6 2.3 minutes for cases 11 to 50 (P < .001). Patients of cases 1 to 10 experienced postoperative stroke (2/68 [2.94%]) not significantly different from patients of later cases (1/122 [0.82%]; P ¼ .292; Table) . Similarly, postoperative mortality rates were similar in the <10 and >10 case groups (1.47% vs 1.64%; P ¼ 1.00). All three strokes and two of the three deaths (both in cases 11-50) occurred in symptomatic patients, which represented 42% of the overall cohort.
Conclusions: A learning curve does exist for the TCAR procedure, but it is relatively steep. After 10 cases, surgeons are able to reduce procedural times by 10% (74.8 to 67.5 minutes) and, more important, flow reversal times by an average of 40% (14.5 to 8.6 minutes). The critical steps in the TCAR procedure may be easily adopted by a broad group of vascular surgeons learning this technique. Objective: Carotid artery stenting (CAS) continues to be an important treatment modality for patients deemed at high risk for carotid endarterectomy. The utility of intravascular ultrasound (IVUS) in carotid intervention is not well characterized. The purpose of this study was to review our results of CAS in veteran patients and to evaluate the effect of IVUS on periprocedural events and long-term outcomes.
Methods: This is a retrospective review of a population of veteran patients from 1998 to 2017. All patients at our institution with carotid artery stenosis who underwent CAS were included in the analysis. Kaplan-Meier analysis was used to determine primary patency and freedom from mortality. Univariate and multivariate logistic regressions were used to compare interventions performed with angiography plus IVUS (AI) vs those performed with angiography alone (AA) with respect to need for reintervention, neurologic events, stent patency, and mortality.
Results: A total of 351 patients were treated with 386 carotid stenting interventions during the study period. Of those interventions, 377 interventions met inclusion criteria, with 258 performed with IVUS and 119 with AA. The reintervention rate for the cohort was 5% (n ¼ 20), with the AI group having a significantly lower reintervention rate, 3% vs 9% in the AA group (P ¼ .0198). The periprocedural neurologic event rates and late neurologic events rates for the AI group were 4% and 1% compared with 3% and 7% for the AA group, respectively, with the late neurologic event difference being statistically significant (P ¼ .0299). The primary patency at 1 year, 3 years, and 5 years was 96%, 52%, and 32% for the AI group vs 94%, 62%, and 50% for the AA group (Fig) . The cumulative freedom from mortality at 1 year, 3 years, and 5 years was 93%, 66%, and 42% for the AI group vs for 94%, 79%, and 62% for the AA group (Fig) . Neither primary patency nor mortality was statistically different between the groups.
Conclusions: Based on the results in this series, CAS can be performed with low long-term rates of neurologic events and need for reinterven- Objective: Carotid artery stenting (CAS) is accepted as an alternative to carotid endarterectomy for high-risk patients with significant carotid occlusive disease. A rare complication of this approach is stent fracture. The incidence and clinical significance of carotid stent fractures are not well studied. To better understand the incidence of stent fracture and to assess whether fracture is associated with in-stent restenosis, we provide this update to our prospectively evaluated CAS patients.
Methods: Our study population includes patients who underwent CAS between January 2002 and December 2017. Patients were consented and prospectively evaluated for stent fractures by anteroposterior and lateral cervical radiographs. All fractured stents were examined by duplex ultrasound at 1 month, 6 months, and annually thereafter, with a minimum 2-year follow-up. The fracture prevalence was then calculated as a percentage of the total number of stents placed. A subset of these patients had a second radiograph 1 to 6 years after the initial radiograph to assess for late fracture development.
Results: A total of 181 patients with 206 stents have been evaluated to date, with 24 fractures identified for a fracture incidence of 11.7% during the course of our study. Of the 206 stents, 95 stents were also evaluated with a second radiograph between 1 and 6 years later, identifying 7 late stent fractures with a late fracture rate of 8.1%. Of the 24 patients with carotid stent fractures, 2 patients developed in-stent restenosis, of whom only one required reintervention.
Conclusions: Carotid artery stent fracture occurs at the rate of 11.7%. Furthermore, late stent fractures have also been identified. Currently, there is not an accepted protocol to assess for stent fractures, nor have there been morbidities identified with stent fractures. Given the significant incidence of stent fracture identified in this study, we recommend further prospective study to confirm the incidence of carotid stent fracture and to assess the relative risk of in-stent restenosis of fractured stents.
Author Disclosures: T. Carle: Nothing to disclose; N. Karani: Nothing to disclose; R. Molnar: Nothing to disclose; J. L. Williams: Nothing to disclose. Methods: From January 1996 to December 2017, there were 6636 consecutive CEAs performed. Data concerning these interventions were prospectively collected in a dedicated database. A post hoc analysis of the database was performed, and 4379 interventions performed in asymptomatic patients were found and divided in two subgroups: patients operated on between 1996 and 1999 (1321 interventions, group 1); and patients operated on between 2013 and 2017 (1179 interventions, group 2). The two groups were compared in terms of preoperative characteristics, surgery and anesthesia techniques, and perioperative results with two tests.
IP115.

Refinements in Surgical and
Results: Patients in group 2 were older than patients in group 1 and more frequently had severe cardiovascular comorbidities. There were no differences between the two groups in terms of degree of stenosis at the side operated on and status of the contralateral carotid artery. All the interventions in group 1 were performed under general anesthesia (GA) with selective shunt insertion on the basis of somatosensory evoked potential monitoring; in group 2, the corresponding figure was 14% (P < .001), whereas the remaining 1015 patients had remifentanil anesthesia with selective shunt insertion on the basis of clinical monitoring. Shunt insertion rates were 9.4% in group 1 and 13.8% in group 2 (P < .001). The frequency of primary closures fell from 39.5% in group 1 to 2.7% in group 2 (P < .001), whereas there was an increase in patch closure in group 2 (from 48% to 94%). Perioperative mortality was 0.4% in group 1 and 0.5% in group 2 (P ¼ .7), whereas perioperative stroke rate was 1% in group 1 and 0.25% in group 2 (P ¼ .01). Thirty-day stroke and death rates were 1.45% and 0.7%, respectively (P ¼ .01). The corresponding values in patients with GA without patch, with GA with patch, and with clinical monitoring with patch were 1.8%, 1.3%, and 0.5%, respectively (P ¼ 0.05). At univariate analysis, the avoidance of shunt, use of patch, and clinical monitoring significantly improved 30-day outcomes; at multivariate analysis, only the avoidance of shunt maintained its significant value (odds ratio, 4.7; 95% confidence interval, 1.7-12.8; P ¼ .002).
Conclusions: The introduction and wide diffusion in our experience of patch closure and remifentanil anesthesia with clinical monitoring allowed significant improvement of the perioperative results of CEA in the last two decades in asymptomatic patients.
Author Disclosures: A. Alessi Innocenti: Nothing to disclose; G. Bassoli: Nothing to disclose; E. Chiti: Nothing to disclose; F. Ciappi: Nothing to disclose; W. Dorigo: Nothing to disclose; F. Masciello: Nothing to disclose; C. Pratesi: Nothing to disclose; S. Speziali: Nothing to disclose. Objective: The role of the carotid plaque fibrous cap in carotid-related stroke risk has been demonstrated in many studies. The aim of this study was to evaluate the relationship between the presence of a carotid plaque ulcer and the perioperative complication risk in a consecutive series/cohort of patients submitted to carotid endarterectomy (CEA) at our academic tertiary hospital.
IP117. Perioperative Complication Risk Prediction
Methods: A retrospective review of a prospectively collected database on consecutive CEAs performed between January 2009 and December 2017 was performed. All patients with a carotid plaque ulcer (defined as a discontinuation in the carotid fibrous cap of >2 mm) at carotid duplex ultrasound were analyzed. Perioperative (30-day) complications considered for analysis were TIA, minor and major stroke, death, myocardial infarction, hemodynamic instability, cervical hematoma, and cranial nerve palsy. The prognostic value of plaque ulcer on the development of perioperative complications was assessed by odds ratio (OR) estimation.
Results: Among 964 CEAs, 158 were performed in symptomatic patients and 806 in asymptomatic patients. A carotid plaque ulcer was detected in 207 patients. Complications are reported in the Table. Plaque ulcer was significantly associated with preoperative presence of neurologic symptoms (OR, 1.51; 95% confidence interval [CI], 1.02-2.22;
